Logo image of ASLE

AERSALE CORP (ASLE) Stock Fundamental Analysis

NASDAQ:ASLE - US00810F1066 - Common Stock

8.94 USD
-0.06 (-0.67%)
Last: 8/27/2025, 11:13:55 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ASLE. ASLE was compared to 68 industry peers in the Aerospace & Defense industry. ASLE has a bad profitability rating. Also its financial health evaluation is rather negative. ASLE is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ASLE was profitable.
ASLE had a negative operating cash flow in the past year.
ASLE had positive earnings in 4 of the past 5 years.
In multiple years ASLE reported negative operating cash flow during the last 5 years.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

ASLE has a worse Return On Assets (-0.88%) than 60.29% of its industry peers.
The Return On Equity of ASLE (-1.40%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.88%
ROE -1.4%
ROIC N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

ASLE's Profit Margin has declined in the last couple of years.
ASLE's Operating Margin has declined in the last couple of years.
The Gross Margin of ASLE (29.07%) is better than 69.12% of its industry peers.
In the last couple of years the Gross Margin of ASLE has declined.
The Profit Margin and Operating Margin are not available for ASLE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.07%
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

ASLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ASLE has more shares outstanding
ASLE has more shares outstanding than it did 5 years ago.
ASLE has about the same debt/assets ratio as last year.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.32 indicates that ASLE is not a great score, but indicates only limited risk for bankruptcy at the moment.
ASLE has a Altman-Z score of 2.32. This is in the lower half of the industry: ASLE underperforms 64.71% of its industry peers.
ASLE has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.33, ASLE is doing good in the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 2.32
ROIC/WACCN/A
WACC10.43%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ASLE has a Current Ratio of 4.54. This indicates that ASLE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.54, ASLE belongs to the top of the industry, outperforming 89.71% of the companies in the same industry.
A Quick Ratio of 0.88 indicates that ASLE may have some problems paying its short term obligations.
ASLE has a Quick ratio of 0.88. This is in the lower half of the industry: ASLE underperforms 70.59% of its industry peers.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 0.88
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 300.00% over the past year.
The Earnings Per Share has been growing by 22.36% on average over the past years. This is a very strong growth
ASLE shows a small growth in Revenue. In the last year, the Revenue has grown by 3.16%.
Measured over the past years, ASLE shows a small growth in Revenue. The Revenue has been growing by 0.45% on average per year.
EPS 1Y (TTM)300%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%500%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%39.27%

3.2 Future

ASLE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 87.10% yearly.
ASLE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.65% yearly.
EPS Next Y155%
EPS Next 2Y88.94%
EPS Next 3Y87.1%
EPS Next 5YN/A
Revenue Next Year8.81%
Revenue Next 2Y8.48%
Revenue Next 3Y13.65%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.93, ASLE can be considered very expensive at the moment.
ASLE's Price/Earnings ratio is a bit cheaper when compared to the industry. ASLE is cheaper than 72.06% of the companies in the same industry.
ASLE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.08.
A Price/Forward Earnings ratio of 13.18 indicates a correct valuation of ASLE.
Based on the Price/Forward Earnings ratio, ASLE is valued cheaper than 97.06% of the companies in the same industry.
ASLE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.93
Fwd PE 13.18
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ASLE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.33
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

ASLE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ASLE's earnings are expected to grow with 87.10% in the coming years.
PEG (NY)0.21
PEG (5Y)1.43
EPS Next 2Y88.94%
EPS Next 3Y87.1%

0

5. Dividend

5.1 Amount

ASLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AERSALE CORP

NASDAQ:ASLE (8/27/2025, 11:13:55 AM)

8.94

-0.06 (-0.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners52.15%
Inst Owner Change0.76%
Ins Owners8.83%
Ins Owner Change-331.01%
Market Cap421.79M
Analysts80
Price Target7.14 (-20.13%)
Short Float %4.44%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-79.82%
Min EPS beat(2)-157.67%
Max EPS beat(2)-1.96%
EPS beat(4)0
Avg EPS beat(4)-83.78%
Min EPS beat(4)-157.67%
Max EPS beat(4)-1.96%
EPS beat(8)1
Avg EPS beat(8)-60.01%
EPS beat(12)3
Avg EPS beat(12)-40.33%
EPS beat(16)7
Avg EPS beat(16)10.17%
Revenue beat(2)1
Avg Revenue beat(2)-13.38%
Min Revenue beat(2)-27.97%
Max Revenue beat(2)1.22%
Revenue beat(4)1
Avg Revenue beat(4)-13.17%
Min Revenue beat(4)-27.97%
Max Revenue beat(4)1.22%
Revenue beat(8)2
Avg Revenue beat(8)-16.53%
Revenue beat(12)3
Avg Revenue beat(12)-14.46%
Revenue beat(16)6
Avg Revenue beat(16)-7.92%
PT rev (1m)7.69%
PT rev (3m)-12.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-70%
EPS NY rev (1m)295.83%
EPS NY rev (3m)-2.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.98%
Revenue NY rev (1m)7.26%
Revenue NY rev (3m)1%
Valuation
Industry RankSector Rank
PE 31.93
Fwd PE 13.18
P/S 1.32
P/FCF N/A
P/OCF N/A
P/B 1.04
P/tB 1.15
EV/EBITDA 33.33
EPS(TTM)0.28
EY3.13%
EPS(NY)0.68
Fwd EY7.59%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS6.79
BVpS8.62
TBVpS7.77
PEG (NY)0.21
PEG (5Y)1.43
Profitability
Industry RankSector Rank
ROA -0.88%
ROE -1.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.07%
FCFM N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
F-Score1
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 8.06
Cap/Depr 70.77%
Cap/Sales 4.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.54
Quick Ratio 0.88
Altman-Z 2.32
F-Score1
WACC10.43%
ROIC/WACCN/A
Cap/Depr(3y)91.07%
Cap/Depr(5y)58.73%
Cap/Sales(3y)3.18%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)300%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%500%
EPS Next Y155%
EPS Next 2Y88.94%
EPS Next 3Y87.1%
EPS Next 5YN/A
Revenue 1Y (TTM)3.16%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%39.27%
Revenue Next Year8.81%
Revenue Next 2Y8.48%
Revenue Next 3Y13.65%
Revenue Next 5YN/A
EBIT growth 1Y70.55%
EBIT growth 3Y-38.5%
EBIT growth 5YN/A
EBIT Next Year219.21%
EBIT Next 3Y99.33%
EBIT Next 5YN/A
FCF growth 1Y77.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y88.1%
OCF growth 3Y-47.9%
OCF growth 5YN/A